Niramai
About
Niramai Health Analytix develops an AI-based medical device called Thermalytix for early breast cancer detection. This non-invasive, radiation-free solution uses thermal imaging and machine learning to analyze temperature patterns, offering an affordable and accessible screening method for women of all ages. The company aims to improve breast cancer mortality rates through early diagnosis and has received regulatory clearances from the US FDA and European CE Mark.
Key facts
At-a-glance profile data
- Website
- niramai.com
- Headquarters
- Bengaluru, India
- Founded
- 2016
- Total funding
- $19M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Oct 2025 | Series B | $6M | - |
| 28 Apr 2022 | Undisclosed round | $6M | AmbiPartha Das |
| 17 Jul 2019 | Undisclosed round | $6M | Dream Incubator |
| 18 Apr 2017 | Undisclosed round | Undisclosed | - |
| 17 Apr 2017 | Seed | $1M | - |
Tech stack
Detected on niramai.com, last scanned 18 Sept 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Niramai raised?
Niramai has raised a total of $19M in funding. The most recent round on record is Series B.